Clinic
Tullahoma Pediatrics PLLC
Tullahoma Pediatrics PLLC was paid $6.06M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoTULLAHOMA PEDIATRICS PLLC
TULLAHOMA, TN 37388
TULLAHOMA, TN 37388
33aNPI1770562142assigned 01/12/2006
33bProvider typeRural Health Clinic/Center
28Total paid$6.06M
24GClaims245,362
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Tennessee
Rank by total paid#6 of 96
Median peer was paid$127K
This provider vs. median48×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,408 | $422K | |
| 2019 | 18,099 | $478K | |
| 2020 | 24,498 | $604K | |
| 2021 | 41,741 | $1.06M | |
| 2022 | 53,177 | $1.20M | |
| 2023 | 49,028 | $1.21M | |
| 2024incomplete | 43,411 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 52,822 | 46,423 | $2.04M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 10% | 14,877 | 12,839 | $633K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 10,906 | 9,608 | $622K |
| 96127 | 8.6% | 45,473 | 33,366 | $521K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 7.7% | 12,494 | 11,383 | $469K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 5,646 | 5,199 | $386K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.4% | 4,982 | 4,402 | $329K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.5% | 3,416 | 3,015 | $214K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 13,096 | 12,256 | $126K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 4,659 | 3,770 | $125K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 12,225 | 5,699 | $114K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 1,389 | 1,187 | $102K |
51 more codes
| 99177 | 1.4% | 10,554 | $87K | |
| 92558 | <1% | 7,470 | $60K | |
| 92551 | <1% | 5,962 | $55K | |
| 96161 | <1% | 3,126 | $52K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 301 | $23K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 560 | $21K |
| 92588 | <1% | 376 | $20K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 169 | $15K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 94 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 414 | $5K |
| 99173 | <1% | 1,468 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 193 | $4K |
| 96160 | <1% | 113 | $3K | |
| 36416 | <1% | 1,664 | $3K | |
| 3008F | <1% | 16,417 | $3K | |
| 90686 | <1% | 2,358 | $2K | |
| 90670 | <1% | 1,887 | $2K | |
| 83655 | <1% | 218 | $2K | |
| 85018 | <1% | 833 | $2K | |
| 90677 | <1% | 464 | $2K | |
| 80061 | Lipid panel | <1% | 113 | $2K |
| 97802 | <1% | 195 | $1K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 13 | $1K |
| 90651 | <1% | 264 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 68 | $968.27 |
| 90671 | <1% | 338 | $687.81 | |
| 69210 | <1% | 13 | $520.55 | |
| 81003 | <1% | 321 | $516.83 | |
| 90619 | <1% | 90 | $504.88 | |
| 94760 | <1% | 288 | $406.71 | |
| 85014 | <1% | 206 | $402.40 | |
| 90716 | <1% | 232 | $366.28 | |
| 90697 | <1% | 436 | $327.56 | |
| 92587 | <1% | 12 | $290.24 | |
| 90661 | <1% | 414 | $178.61 | |
| 90707 | <1% | 215 | $167.54 | |
| 90633 | <1% | 492 | $167.11 | |
| 90734 | <1% | 41 | $162.85 | |
| 90698 | <1% | 263 | $127.31 | |
| 90688 | <1% | 65 | $71.24 | |
| 90715 | <1% | 50 | $55.96 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 39 | $3.09 |
| 99072 | <1% | 3,046 | $1.89 | |
| 90680 | <1% | 417 | $1.00 | |
| 90681 | 0% | 16 | $0.00 | |
| 90685 | 0% | 29 | $0.00 | |
| 90674 | 0% | 352 | $0.00 | |
| 99000 | 0% | 504 | $0.00 | |
| 90696 | 0% | 17 | $0.00 | |
| 90723 | 0% | 103 | $0.00 | |
| 90647 | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTUCK, CAROLINE (ADMINISTRATOR)